Table 1: Baseline characteristics of the included patients.
Variable |
Letrozole (Group A) (n = 45) |
Letrozole plus Gonadotropin (Group B) (n = 45) |
Total (n = 90) |
P-value¥ |
|||
Mean |
Standard Deviation |
Mean |
Standard Deviation |
Mean |
Standard Deviation |
||
Age (year) |
26.0 |
3.5 |
24.2 |
3.1 |
25.1 |
3.4 |
0.015* |
BMI (kg/m2) |
28.6 |
2.3 |
28.0 |
2.1 |
28.3 |
2.2 |
0.156 |
Prior Infertility period (year) |
2.6 |
1.0 |
2.5 |
0.8 |
2.6 |
0.9 |
0.902 |
FSH (mIU/mL) |
5.8 |
1.2 |
5.8 |
1.1 |
5.8 |
1.2 |
0.948 |
Progesterone (ng/mL) |
1.7 |
0.7 |
1.5 |
0.4 |
1.6 |
0.6 |
0.127 |
LH (IU/L) |
6.0 |
1.2 |
6.0 |
1.1 |
6.0 |
1.2 |
0.900 |
Baseline E2(pg/mL) |
47.3 |
15.6 |
44.9 |
15.9 |
46.1 |
15.7 |
0.445 |
Prolactin (ng/mL) |
15.8 |
4.0 |
17.8 |
5.3 |
16.8 |
4.8 |
0.104 |
TSH (mU/L) |
2.2 |
0.6 |
1.9 |
0.6 |
2.0 |
0.6 |
0.018* |
¥Mann–Whitney U test; *Significant P-value